Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/10632
|
| Title: | Elimination of undifferentiated human embryonic stem cells by cardiac glycosides |
| Authors: | Lin, YT;Wang, CK;Yang, SC;Hsu, SC;Lin, H;Chang, FP;Kuo, TC;Shen, CN;Chiang, PM;Hsiao, M;Lu, FL;Lu, J |
| Contributors: | Division of Vaccine Research and Development |
| Abstract: | An important safety concern in the use of human pluripotent stem cells (hPSCs) is tumorigenic risk, because these cells can form teratomas after an in vivo injection at ectopic sites. Several thousands of undifferentiated hPSCs are sufficient to induce teratomas in a mouse model. Thus, it is critical to remove all residue-undifferentiated hPSCs that have teratoma potential before the clinical application of hPSC-derived cells. In this study, our data demonstrated the cytotoxic effects of cardiac glycosides, such as digoxin, lanatoside C, bufalin, and proscillaridin A, in human embryonic stem cells (hESCs). This phenomenon was not observed in human bone marrow mesenchymal stem cells (hBMMSCs). Most importantly, digoxin and lanatoside C did not affect the stem cells' differentiation ability. Consistently, the viability of the hESC-derived MSCs, neurons, and endothelium cells was not affected by the digoxin and lanatoside C treatment. Furthermore, the in vivo experiments demonstrated that digoxin and lanatoside C prevented teratoma formation. To the best of our knowledge, this study is the first to describe the cytotoxicity and tumor prevention effects of cardiac glycosides in hESCs. Digoxin and lanatoside C are also the first FDA-approved drugs that demonstrated cytotoxicity in undifferentiated hESCs. |
| Date: | 2017-07-13 |
| Relation: | Scientific Reports. 2017 Jul 13;7:Article number 5289. |
| Link to: | http://dx.doi.org/10.1038/s41598-017-05616-2 |
| JIF/Ranking 2023: | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=2045-2322&DestApp=IC2JCR |
| Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:000425910400001 |
| Cited Times(Scopus): | http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85024103546 |
| Appears in Collections: | [許素菁] 期刊論文
|
Files in This Item:
| File |
Description |
Size | Format | |
|---|
| PUB28706279.pdf | | 4473Kb | Adobe PDF | 390 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|
